Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5472885

CCN(c1ccccn1)S(=O)(=O)c1ccc(Cl)c(-n2c(=O)[nH]c3ccccc3c2=O)c1.O=C(O)C(F)(F)F

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.39
HTT P42858 1/20 0.39
GNRHR P30968 7/20 0.38
TP53 P04637 1/20 0.38
KMT2A Q03164 1/20 0.36
HCRTR1 O43613 1/20 0.36
HCRTR2 O43614 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PTGDR2 Q9Y5Y4 1/20 0.35
C1R P00736 1/20 0.35
PRSS1 P07477 1/20 0.35
GAA P10253 2/20 0.34
NPEPPS P55786 1/20 0.34
ALPL P05186 1/20 0.34
ALPI P09923 1/20 0.34
MAPT P10636 1/20 0.34
ALPG P10696 1/20 0.34
NPC1 O15118 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
GRM4 Q14833 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5461048 0.90 GNRHR (0.44) KDM4EHTTGNRHRTP53L3MBTL1
Trifluoroacetic Acid SCHEMBL5467496 0.82 GNRHR (0.38) KDM4EHTTGNRHRTP53KMT2A
SCHEMBL5473782 0.82 GNRHR (0.49) KDM4EHTTGNRHRTP53KMT2A
SCHEMBL5464454 0.82 MAPT (0.52) KDM4EHTTGNRHRTP53KMT2A
Trifluoroacetic Acid SCHEMBL5467389 0.80 GNRHR (0.51) KDM4EHTTGNRHRTP53KMT2A
Trifluoroacetic Acid SCHEMBL5479474 0.79 MAPT (0.40) KDM4EHTTKMT2AC1RPRSS1
SCHEMBL5461789 0.78 KDM4E (0.52) KDM4EHTTGNRHRTP53KMT2A
SCHEMBL5470082 0.78 RXFP1 (0.53) KDM4EHTTGNRHRTP53KMT2A
Trifluoroacetic Acid SCHEMBL5461737 0.78 GNRHR (0.40) KDM4EHTTGNRHRTP53L3MBTL1
Trifluoroacetic Acid SCHEMBL5474127 0.77 APOBEC3A (0.45) KDM4EHTTGNRHRTP53KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070010537-A1 Fused pyramidine derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-01-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070010537-A1 Fused pyramidine derivative and use thereof NR5A1, GNRHR, RXFP3 KDM4E 4108/4885HTT 2381/4885GNRHR 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.